Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Chandan Healthcare IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Chandan Healthcare IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹ 8.14 and post-issue EPS of ₹ 6.66 for FY24. The pre-issue P/E ratio is 19.53x, while the post-issue P/E ratio is 23.89x against the Industry P/E ratio is 75x. The company's ROCE for FY24 is 35.20%, ROE for FY24 is 47.50% and RoNW 39.54%. The Annualised EPS based on the latest financial data is ₹ 10.76 and PE ratio is 14.77x. These metrics suggest that the IPO is fairly priced.
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | ₹8.14 |
| EPS Post IPO (Rs.) | ₹6.66 |
| Adjusted 12M EPS Post IPO (Rs.) | |
| P/E Pre IPO | 19.53 |
| P/E Post IPO | 23.89 |
| Adjusted 12M P/E Post IPO | |
| ROE | 47.50% |
| ROCE | 35.20% |
| P/BV | 3.42 |
| Debt/Equity | 1.02 |
| RoNW | 39.54% |
| EBITDA Margin | |
| PAT Margin |
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
